Shopping Cart

Imagion Biosystem's August Newsletter

Imagion Biosystem's August Newsletter

In this issue:

  • FDA “Breakthrough Device Designation”
  • Tox Study Completion
  • WMIC 2019 Poster
  • Q&A with Bob Proulx

Read the issue.

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.